Social consequences of sleep disordered breathing on patients and their partners: A controlled national study

European Respiratory Journal

Volumn 43, Issue 1, 2014, Pages 134-144

  Jennum, Poul ^a   Ibsen, Rikke ^b   Kjellberg, Jakob ^c  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

^b Itracks   (Denmark)

^c KORA The Danish Institute for Local and Regional Government Research   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

RESPIRATORY TRACT AGENT;

ADULT; AGED; CONTROLLED STUDY; COST BENEFIT ANALYSIS; COST OF ILLNESS; DATA BASE; DEMOGRAPHY; DENMARK; DISEASE REGISTRY; DISEASE SEVERITY; DRUG USE; FEMALE; HEALTH CARE COST; HUMAN; ICD-10-PCS; LOWEST INCOME GROUP; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; OBESITY HYPOVENTILATION SYNDROME; PRIORITY JOURNAL; PROSPECTIVE STUDY; RETROSPECTIVE STUDY; REVIEW; SLEEP DISORDERED BREATHING; SOCIOECONOMICS; SPOUSE; UNEMPLOYMENT; VERY ELDERLY; YOUNG ADULT;

ADULT; AGED; AGED, 80 AND OVER; CASE-CONTROL STUDIES; COST OF ILLNESS; DENMARK; DRUG COSTS; FEMALE; HEALTH CARE COSTS; HEALTH SERVICES; HUMANS; INCOME; MALE; MIDDLE AGED; OBESITY HYPOVENTILATION SYNDROME; SLEEP APNEA SYNDROMES; SPOUSES; UNEMPLOYMENT; YOUNG ADULT;

EID: 84891936391     PISSN: 09031936     EISSN: 13993003     Source Type: Journal    
DOI: 10.1183/09031936.00169212     Document Type: Review

References (37)

1. Jennum P, Riha RL. Epidemiology of sleep apnoea/hypopnoea syndrome and sleep-disordered breathing. Eur Respir J 2009; 33: 907-914.
2. Jennum P, Kjellberg J. Health, social and economical consequences of sleep-disordered breathing: A controlled national study. Thorax 2011; 66: 560-566.
3. Laaban JP, Mounier L, Roque d'Orbcastel O, et al. Cardiovascular risk factors in men and women with obstructive sleep apnoea syndrome. Respir Med 2010; 104: 1063-1068.
4. Li X, Sundquist K, Sundquist J. Socioeconomic status and occupation as risk factors for obstructive sleep apnea in Sweden: A population-based study. Sleep Med 2008; 9: 129-136.
5. Mart́nez-Garća MA, Soler-Cataluna JJ, Ejarque-Mart́nez L, et al. Continuous positive airway pressure treatment reduces mortality in patients with ischemic stroke and obstructive sleep apnea: A 5-year follow-up study. Am J Respir Crit Care Med 2009; 180: 36-41.
6. Punjabi NM, Caffo BS, Goodwin JL, et al. Sleep-disordered breathing and mortality: A prospective cohort study. PLoS Med 2009; 6: E1000132.
7. Tarasiuk A, Greenberg-Dotan S, Simon T, et al. Low socioeconomic status is a risk factor for cardiovascular disease among adult obstructive sleep apnea syndrome patients requiring treatment. Chest 2006; 130: 766-773.
8. Kapur V, Blough DK, Sandblom RE, et al. The medical cost of undiagnosed sleep apnea. Sleep 1999; 22: 749-755.
9. Gander P, Scott G, Mihaere K, et al. Societal costs of obstructive sleep apnoea syndrome. NZ Med J 2010; 123: 13-23.
10. Pagel JF. Obstructive sleep apnea (OSA) in primary care: Evidence-based practice. J Am Board Fam Med 2007; 20: 392-398.
11. Pietzsch JB, Garner A, Cipriano LE, et al. An integrated health-economic analysis of diagnostic and therapeutic strategies in the treatment of moderate-to-severe obstructive sleep apnea. Sleep 2011; 34: 695-709.
12. Guest JF, Helter MT, Morga A, et al. Cost-effectiveness of using continuous positive airway pressure in the treatment of severe obstructive sleep apnoea/hypopnoea syndrome in the UK. Thorax 2008; 63: 860-865.
13. Tan MC, Ayas NT, Mulgrew A, et al. Cost-effectiveness of continuous positive airway pressure therapy in patients with obstructive sleep apnea-hypopnea in British Columbia. Can Respir J 2008; 15: 159-165.
14. Tripathi A, Jerrell JM, Stallworth Jr. Cost-effectiveness of adenotonsillectomy in reducing obstructive sleep apnea, cerebrovascular ischemia, vaso-occlusive pain, and ACS episodes in pediatric sickle cell disease. Ann Hematol 2011; 90: 145-150.
15. Gustavsson A, Svensson M, Jacobi F, et al. Cost of disorders of the brain in Europe 2010. Eur Neuropsychopharmacol 2011; 21: 718-779.
16. Fietze I. The Danish study on cost effectiveness in sleep related breathing disorders - a possible example for Europe. Thorax 2011; 66: 556-558.
17. Breugelmans JG, Ford DE, Smith PL, et al. Differences in patient and bed partner-assessed quality of life in sleepdisordered breathing. Am J Respir Crit Care Med 2004; 170: 547-552.
18. Virkkula P, Bachour A, Hytonen M, et al. Patient- and bed partner-reported symptoms, smoking, and nasal resistance in sleep-disordered breathing. Chest 2005; 128: 2176-2182.
19. Simon-Tuval T, Reuveni H, Greenberg-Dotan S, et al. Low socioeconomic status is a risk factor for CPAP acceptance among adult OSAS patients requiring treatment. Sleep 2009; 32: 545-552.
20. Lynge E, Sandegaard JL, Rebolj M. The Danish National Patient Register. Scand J Public Health 2011; 39: Suppl. 7, 30-33.
21. Efron B, Tibshirani RJ. An Introduction to the Bootstrap. London, Chapman & Hall, 1993.
22. Ashtyani H, Hutter DA. Collateral damage: The effects of obstructive sleep apnea on bed partners. Chest 2003; 124: 780-781.
23. Beninati W, Harris CD, Herold DL, et al. The effect of snoring and obstructive sleep apnea on the sleep quality of bed partners. Mayo Clin Proc 1999; 74: 955-958.
24. Doherty LS, Kiely JL, Lawless G, et al. Impact of nasal continuous positive airway pressure therapy on the quality of life of bed partners of patients with obstructive sleep apnea syndrome. Chest 2003; 124: 2209-2214.
25. Parish JM, Lyng PJ. Quality of life in bed partners of patients with obstructive sleep apnea or hypopnea after treatment with continuous positive airway pressure. Chest 2003; 124: 942-947.
26. Smith AK, Togeiro SM, Tufik S, et al. Disturbed sleep and musculoskeletal pain in the bed partner of patients with obstructive sleep apnea. Sleep Med 2009; 10: 904-912.
27. Thomopoulos C, Michalopoulou H, Kasiakogias A, et al. Resistant hypertension and obstructive sleep apnea: The sparring partners. Int J Hypertens 2011; 2011: 947246.
28. Uloza V, Balsevicius T, Sakalauskas R, et al. Changes in emotional state of bed partners of snoring and obstructive sleep apnea patients following radiofrequency tissue ablation: A pilot study. Sleep Breath 2010; 14: 125-130.
29. Aloia MS. Social factors associated with CPAP acceptance. Sleep 2009; 32: 443-444.
30. Charokopos N, Leotsinidis M, Tsiamita M, et al. Sleep apnea syndrome in a referral population in Greece: Influence of social factors. Lung 2007; 185: 235-240.
31. McDowell A. Spousal involvement and CPAP adherence: A two-way street Sleep Breath 2011; 15: 269-270.
32. Paine SJ, Harris RB, Mihaere KM. Managing obstructive sleep apnoea and achieving equity: Implications for health services. N Z Med J 2011; 124: 97-104.
33. Brin YS, Reuveni H, Greenberg S, et al. Determinants affecting initiation of continuous positive airway pressure treatment. Isr Med Assoc J 2005; 7: 13-18.
34. Tarasiuk A, Reznor G, Greenberg-Dotan S, et al. Financial incentive increases CPAP acceptance in patients from low socioeconomic background. PLoS One 2012; 7: E33178.
35. Jennum P. Quality of life, co-morbidity and obstructive sleep apnoea. Clin Respir J 2010; 4: 129-130.
36. Laitinen LA, Anttalainen U, Pietinalho A, et al. Sleep apnoea: Finnish National guidelines for prevention and treatment 2002-2012. Respir Med 2003; 97: 337-365.
37. Tzischinsky O, Shahrabani S, Peled R. Factors affecting the decision to be treated with continuous positive airway pressure for obstructive sleep apnea syndrome. Isr Med Assoc J 2011; 13: 413-419.